Literature DB >> 9647876

Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome.

H S Willenberg1, C A Stratakis, C Marx, M Ehrhart-Bornstein, G P Chrousos, S R Bornstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9647876     DOI： 10.1056/NEJM199807023390105

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  [Progress in molecular medicine: "laser capture microdissection"].

Authors:  S R Bornstein; H S Willenberg; W A Scherbaum
Journal:  Med Klin (Munich)       Date:  1998-12-15

2.  Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.

Authors:  Nobuhiro Miyamura; Tetsuya Taguchi; Yusuke Murata; Kayo Taketa; Shinsuke Iwashita; Kazuya Matsumoto; Takeshi Nishikawa; Tetsushi Toyonaga; Michiharu Sakakida; Eiichi Araki
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

Review 3.  Aberrant expression of hormone receptors in adrenal Cushing's syndrome.

Authors:  Stavroula Christopoulos; Isabelle Bourdeau; André Lacroix
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

4.  Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex.

Authors:  J Kero; M Poutanen; F P Zhang; N Rahman; A M McNicol; J H Nilson; R A Keri; I T Huhtaniemi
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

5.  c-KIT oncogene expression in PRKAR1A-mutant adrenal cortex.

Authors:  Kiran Nadella; Fabio R Faucz; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2020-10       Impact factor: 5.678

6.  Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues.

Authors:  C G Ziegler; J W Brown; A V Schally; A Erler; L Gebauer; A Treszl; L Young; L M Fishman; J B Engel; H S Willenberg; S Petersenn; G Eisenhofer; M Ehrhart-Bornstein; S R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-27       Impact factor: 11.205

7.  Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors.

Authors:  Hui-Pin Hsiao; Lawrence S Kirschner; Isabelle Bourdeau; Margaret F Keil; Sosipatros A Boikos; Somya Verma; Audrey J Robinson-White; Maria Nesterova; André Lacroix; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-06-09       Impact factor: 5.958

Review 8.  [Adrenal gland tumors].

Authors:  H S Willenberg; D Zschucke; S R Bornstein
Journal:  Internist (Berl)       Date:  2007-09       Impact factor: 0.743

9.  Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells.

Authors:  C G Ziegler; M Ullrich; A V Schally; R Bergmann; J Pietzsch; L Gebauer; K Gondek; N Qin; K Pacak; M Ehrhart-Bornstein; G Eisenhofer; S R Bornstein
Journal:  Mol Cell Endocrinol       Date:  2012-12-23       Impact factor: 4.102

10.  Impaired adrenal stress response in Toll-like receptor 2-deficient mice.

Authors:  Stefan R Bornstein; Paula Zacharowski; Ralf R Schumann; Andreas Barthel; Nguyen Tran; Claudia Papewalis; Valeria Rettori; Samuel M McCann; Klaus Schulze-Osthoff; Werner A Scherbaum; Jörg Tarnow; Kai Zacharowski
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-16       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.